34Dispensing fee

34 Dispensing fee

(1) For the purposes of subparagraphs 32(1)(a)(iii), (b)(ii) and (c)(iv): (a) the dispensing fee for the supply of an HSD pharmaceutical benefit is: (i) if the benefit has a drug mentioned in subsection (2) in the form mentioned in that subsection for the drug—the extemporaneously‑prepared dispensing fee (within the meaning of the Approved Pharmacists Commonwealth Price Determination); or (ii) if subparagraph (i) does not apply—the ready‑prepared dispensing fee (within the meaning of that Determination); and (b) if the authorised prescriber who prescribed the benefit, instead of directing a repeated supply of the benefit, directed the supply on one occasion of a quantity or number of units of the benefit, not exceeding the total quantity or number of units that could be prescribed if the authorised prescriber directed a repeated supply, the dispensed price for the supply of the benefit includes: (i) only one dispensing fee; and (ii) only one dangerous drug fee.

Note: See section 49 of the Regulations for the circumstances in which such a supply may be directed.

(2) For the purpose of subparagraph (1)(a)(i), the drugs and the forms for the drugs are as follows: (a) mycophenolic acid as a powder for oral suspension containing mycophenolate mofetil 1g per 5 mL, 165mL; (b) valganciclovir as a powder for oral solution 50mg (as hydrochloride) per mL, 100 mL.